Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2017

Oct 17, 2017

32044_dirs_2017-10-17_366a2e6f-d2e0-40b0-ae0f-0b9c23cb9bc6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2017-10-16

Reporting Person: Reed Thomas D. (Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-10-16 Common Stock M 29692 $2.64 Acquired 93809 Direct
2017-10-16 Common Stock M 8906 $2.64 Acquired 102715 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-10-16 Option to Purchase Common Stock (Right to Buy) $2.64 M 29692 Disposed 2017-11-15 Common Stock (29692) Direct
2017-10-16 Option to Purchase Common Stock (Right to Buy) $2.64 M 8906 Disposed 2018-02-20 Common Stock (8906) Direct

Footnotes

F1: The option was immediately exercisable.